AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析

◆英語タイトル:AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14229
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AbbVie Inc (ABBV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virology and metabolic therapy areas. The company also offers medicines for neurological disorders and other serious health conditions. AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies. The company commercializes its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc Key Recent Developments

Feb 27,2019 Top pharma executives testify before US Senate over high prices
Feb 25,2019 AbbVie and Voyager deepen alliance to include Parkinson’s
Feb 19,2019 Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19,2019 FTC enters global settlement to resolve reverse-payment charges against Teva

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AbbVie Inc – Key Facts
AbbVie Inc – Key Employees
AbbVie Inc – Key Employee Biographies
AbbVie Inc – Major Products and Services
AbbVie Inc – History
AbbVie Inc – Company Statement
AbbVie Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AbbVie Inc – Business Description
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: Canada
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: United Kingdom
Performance
Geographical Segment: United States
Performance
R&D Overview
AbbVie Inc – Corporate Strategy
AbbVie Inc – SWOT Analysis
SWOT Analysis – Overview
AbbVie Inc – Strengths
AbbVie Inc – Weaknesses
AbbVie Inc – Opportunities
AbbVie Inc – Threats
AbbVie Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
AbbVie Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 27, 2019: Top pharma executives testify before US Senate over high prices
Feb 25, 2019: AbbVie and Voyager deepen alliance to include Parkinson’s
Feb 19, 2019: Teva finalizes settlement with Federal Trade Commission to resolve all outstanding litigation between the parties
Feb 19, 2019: FTC enters global settlement to resolve reverse-payment charges against Teva
Feb 12, 2019: AbbVie and Teneobio to co-develop new drug for multiple myeloma
Feb 05, 2019: US Senate invites seven pharma majors to testify on price hikes
Jan 28, 2019: AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) – First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Jan 25, 2019: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
Jan 18, 2019: https://news.abbvie.com/news/press-releases/abbvie-provides-update-on-phase-3-study-ibrutinib-imbruvica-in-metastatic-pancreatic-cancer.htm
Jan 18, 2019: AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA) in Metastatic Pancreatic Cancer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AbbVie Inc, Key Facts
AbbVie Inc, Key Employees
AbbVie Inc, Key Employee Biographies
AbbVie Inc, Major Products and Services
AbbVie Inc, History
AbbVie Inc, Subsidiaries
AbbVie Inc, Key Competitors
AbbVie Inc, Ratios based on current share price
AbbVie Inc, Annual Ratios
AbbVie Inc, Annual Ratios (Cont...1)
AbbVie Inc, Annual Ratios (Cont...2)
AbbVie Inc, Interim Ratios
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
AbbVie Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
AbbVie Inc, Performance Chart (2014 - 2018)
AbbVie Inc, Ratio Charts
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
AbbVie Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • curasan AG (CUR):企業の財務・戦略的SWOT分析
    curasan AG (CUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Competitive Power Ventures Inc:企業の戦略的SWOT分析
    Competitive Power Ventures Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • International Drug Development Institute-製薬・医療分野:企業M&A・提携分析
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Allianz France S.A.:企業の戦略・SWOT・財務分析
    Allianz France S.A. - Strategy, SWOT and Corporate Finance Report Summary Allianz France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Peters Surgical:医療機器:M&Aディール及び事業提携情報
    Summary Peters Surgical (Peters), a subsidiary of Eurazeo SA, is a medical device company that designs, manufactures and distributes surgical products. The company offers products such as catheters, sutures, surgical glue, cardiac ring, single use instrument and accessories for surgical procedures. …
  • Ottogi Corporation:企業の戦略・SWOT・財務情報
    Ottogi Corporation - Strategy, SWOT and Corporate Finance Report Summary Ottogi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nigerian National Petroleum Corporation:企業の戦略的SWOT分析
    Nigerian National Petroleum Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Bioqual Inc (BIOQ):企業の財務・戦略的SWOT分析
    Summary Bioqual Inc (Bioqual) is a provider of contract research services which focuses on in vivo models of human diseases such as AIDS, influenza, RSV infection flavivirus infections including zika and dengue, malaria, hepatitis and cancer. The company evaluates vaccines, vaccine therapeutics, mic …
  • Cox & Kings Limited:企業の戦略・SWOT・財務分析
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sam’s West Inc:企業の戦略的SWOT分析
    Sam's West Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Black Hills Corp (BKH):電力:M&Aディール及び事業提携情報
    Summary Black Hills Corp (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, and wind …
  • Aker ASA (AKER):企業の財務・戦略的SWOT分析
    Aker ASA (AKER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Eidgenossische Technische Hochschule Zurich-医療機器分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • Pan Malaysia Holdings Berhad:企業の戦略・SWOT・財務分析
    Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Malaysian Resources Corporation Berhad (MRCB):企業の財務・戦略的SWOT分析
    Malaysian Resources Corporation Berhad (MRCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • GeoVax Labs Inc (GOVX)-製薬・医療分野:企業M&A・提携分析
    Summary GeoVax Labs Inc (GeoVax) is a clinical-stage biotechnology company, which develops human vaccines for diseases caused by HIV, cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus o …
  • Samsung SDS Co Ltd (018260):企業の財務・戦略的SWOT分析
    Samsung SDS Co Ltd (018260) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析
    Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆